Key stakeholders' perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa

Conclusions: Strategies to address barriers to PrEP uptake and use during trials and post-trial access, such as PrEP demand creation, education and counselling, addressing stigma, support for daily pill-taking and increased post-trial access, are urgently needed.PMID:36951406 | DOI:10.2989/16085906.2023.2169177

Source: African Journal of AIDS Research - March 23, 2023 Category: African Health Authors: Ivana Beesham Cecilia Milford Dvora L Joseph Davey Jenni Smit Leila E Mansoor Mags Beksinska Source Type: research